双调蛋白特异性-双螺旋寡核糖核苷酸,包含双螺旋寡核糖核苷酸的双螺旋寡核糖核苷酸...的制作方法_2

文档序号:8460345阅读:来源:国知局
寡核糖核苷酸结构以及制备该双链 寡核糖核苷酸结构的方法。
[0030] 本发明的另一个目的是提供一种用于预防或治疗呼道疾病尤其指COPD和/或IPF 的药物组合物,该组合物包含双调蛋白特异性-双链寡核糖核苷酸或者包含所述双链寡核 糖核苷酸的双链寡核糖核苷酸结构作为活性成分。
[0031] 本发明的又另一个目的是通过利用双调蛋白特异性-双链寡核糖核苷酸或者包 含上述双链寡核糖核苷酸的双链寡核糖核苷酸结构,提供一种用于治疗呼吸道疾病尤其指 coro和/或ipf的药物组合物。
[0032] 本发明的其它特征和实施方式在以下的具体描述和所附权利要求书中更加清晰。
【附图说明】
[0033] 图1是显示分别经30种不同siRNAs各20nM处理过的变异细胞中的双调蛋白mRNA 的相对表达水平的图表,上述30种siRNAs分别包含一条有义链,所述有义链分别具有SEQ ID NO: 1至30的序列。
[0034] NC:双调蛋白mRNA在由未经双调蛋白特异性-siRNA处理过的细胞(对照组)得 来的所有RNA中的表达水平。NC的值设定为100%,相对于NC来衡量分别由每一种siRNA 引起的双调蛋白的相对表达水平。
[0035] 图2是显示分别经不同浓度(0.2、0. 1和5nM)的siRNA处理过的成纤维细胞株中 双调蛋白mRNA的相对表达水平的图表,上述不同浓度的siRNAs分别包含一条有义链,所述 有义链分别具有SEQID NO:8,9和28的序列。
[0036] 图3是显示分别经不同种类的siRNAs各20nM处理过的变异细胞中的双调蛋白 mRNA的相对表达水平的图表,上述siRNAs分别包含一条有义链,所述有义链分别具有SEQ ID NO:31至50的序列。
【具体实施方式】
[0037] 除另有定义外,本文中使用的所有技术和科学术语具有与本发明所属领域内的普 通技术人员对上述术语通常的理解相同的含义。一般地,本文使用的术语和试验方法是本 领域中熟知和常用的。
[0038] 本发明提供了一种具有抑制双调蛋白表达能力的双链寡核糖核苷酸。本发明的 双链寡核糖核苷酸的例子包括但不限于siRNA(短干扰性RNA),shRNA(短发夹RNA)和 miRNA (微小 RNA)。
[0039] 此外,应理解,用作拮抗剂miRNA的单链miRNA抑制剂也在本发明的双链寡核糖核 苷酸范围内。
[0040] 下文中,将用SiRNA的实例来描述本发明的双链寡核糖核苷酸。然而,对于本领域 内的技术人员来说,显然本发明的双链寡核糖核苷酸不限于siRNA,除siRNA之外具有相同 特征的物质也可适用于双链寡核糖核苷酸上。
[0041] 特别地,本发明提供了一种双调蛋白特异性-siRNA,该siRNA包含第一寡核糖核 苷酸,它是具有任意一条选自以下SEQIDNO: 1至230的序列的有义链,以及第二寡核糖核 苷酸,它是具有与有义链互补的序列的反义链:
[0042] 5 '-ggaguaugauaaugaacca-3' (SEQ ID NO: 1),
[0043] 5' -caguaguagcugucacuau-3' (SEQ ID N0:2),
[0044] 5' -agacucacagcgaggauga-3' (SEQIDNO:3),
[0045] 5' -cacaaauauccggcuauau-3' (SEQIDN0:4),
[0046] 5 ' -caccauaagcgaaaugccu-3' (SEQIDNO: 5),
[0047] 5' -gauuacuuuggugaacggu-3' (SEQIDN0:6),
[0048] 5' -caguugucacuuuuuauga-3' (SEQIDN0:7),
[0049] 5' -ggaccuauccaagauugca-3' (SEQIDN0:8),
[0050] 5' -cguuaucacagugcaccuu-3' (SEQIDN0:9),
[0051] 51 -ccuagcugaggacaaugca-3/(SEQIDNO:10),
[0052] 5' -ggaagagagguuuccacca-3' (SEQIDNO: 11),
[0053] 5' -cucagaggaguaugauaau-3' (SEQIDNO:l2),
[0054] 5' -cgguggacuugagcuuucu-3' (SEQIDNO:13),
[0055] 5' -gguggugacaugcaauugu-3' (SEQIDNO:14),
[0056] 5' -cagggaauaugaaggagaa-3' (SEQIDNO: 15),
[0057] 5' -ggaggcuucgacaagaaaa-3' (SEQIDNO: 16),
[0058] 5' -ccgguggaaccaaugagaa-3' (SEQIDNO:I7),
[0059] 51 -ccggcuauauuauagauga-3/(SEQIDNO:18),
[0060] 5' -agaauccaugcacugccaa-3' (SEQIDNO: 19),
[0061] 5' -caaggaccuauccaagauu-3' (SEQIDN0:20),
[0062] 51 -caaauauccggcuauauua-3/(SEQIDNO:21),
[0063] 5' -gggacuacgacuacucaga-3' (SEQIDN0:22),
[0064] 5' -gcgaaugcagauacaucga-3' (SEQIDNO:23),
[0065] 5' -gccacaccggaaaugacau-3' (SEQIDN0:24),
[0066] 5' -agaguugaacaggugauua-3' (SEQIDN0:25),
[0067] 5' -gaaccacaaauauccggcu-3' (SEQIDNO: 26),
[0068] 5' -cauaagcgaaaugccuucu-3' (SEQIDN0:27),
[0069] 5' -guuuccaccauaagcgaaa-3' (SEQIDN0:28),
[0070] 5f -caggugauuaagcccaaga-3/(SEQIDNO:29),
[0071] 5' -ccacaccggaaaugacauu-3' (SEQIDN0:30),
[0072] 5' -gagugaaaugccuucuagu-3' (SEQIDN0:31),
[0073] 5' -cagaguugaacagguaguu-3' (SEQIDN0:32),
[0074] 5' -cuggauuggaccucaauga-3' (SEQIDN0:33),
[0075] 5' -gaaaacucacagcaugauu-3' (SEQIDN0:34),
[0076] 5 ' -gaaacuucgacaagagaau-3' (SEQIDNO: 35),
[0077] 5' -caggaaauaugaaggagaa-3' (SEQIDN0:36),
[0078] 5' -gcaaauauauagagcaccu-3' (SEQIDN0:37),
[0079] 5' -ggugcugucgcucuugaua-3' (SEQIDN0:38),
[0080] 5' -ucagaguugaacagguagu-3' (SEQIDN0:39),
[0081] 5' -gaaagaaacuucgacaaga-3' (SEQIDNO:40),
[0082] 5' -gacaauacgucaggaaaua-3' (SEQIDN0:41),
[0083] 5' -cggcucaggccauuaugcu-3' (SEQIDNO:42),
[0084] 5' -ggaccacagugcugaugga-3' (SEQIDNO:43),
[0085] 5' -gcugcuggauuggaccuca-3' (SEQIDN0:44),
[0086] 5' -guuauuacaguccagcuua-3' (SEQIDNO:45),
[0087] 5' -uggaccucaaugacaccua-3' (SEQIDN0:46),
[0088] 51 -cuggcuauauugucgauga-3/(SEQIDNO:47),
[0089] 5' -gacggaaagugaaaauacu-3' (SEQIDN0:48),
[0090] 5' -gcagccauagcugccuuua-3' (SEQIDN0:49),
[0091] 5' -ggagccgacuaugacuacu-3' (SEQIDN0:50),
[0092] 5' -guaugauaacgaaccacaa-3' (SEQIDN0:51),
[0093] 5' -agugaaaugccuucuagua-3' (SEQIDNO:52),
[0094] 5 ' -gauaacgaaccacaaauac-3' (SEQIDNO:53),
[0095] 5' -ugcauuagcagccauagcu-3' (SEQIDN0:54),
[0096] 51 -cgggagccgacuaugacua-3/(SEQIDNO:55),
[0097] 5' -ccgacuaugacuacucaga-3' (SEQIDN0:56),
[0098] 5' -gcauucacggagaaugcaa-3' (SEQIDN0:57),
[0099] 51 -ccaugaaaacucacagcau-3/(SEQIDNO:58),
[0100] 5' -cagcaugauugacaguagu-3' (SEQIDN0:59),
[0101] 5' -cuuagaagacaauacguca-3' (SEQIDN0:60),
[0102] 5' -ugacuacucagaagaguau-3' (SEQIDN0:61),
[0103] 5' -agaguugaacagguaguua-3' (SEQIDN0:62),
[0104] 5' -auauauagagcaccuggaa-3' (SEQIDN0:63),
[0105] 5' -agcagccauagcugccuuu-3' (SEQIDN0:64),
[0106] 51 -gaguugaacagguaguuaa-3r(SEQIDNO:65),
[0107] 5' -cauucacggagaaugcaaa-3' (SEQIDNO:66),
[0108] 5' -ucaggaaauaugaaggaga-3' (SEQIDNO:67),
[0109] 5' -cagaagaguaugauaacga-3' (SEQIDNO:68),
[0110] 5' -gcuguuauuacaguccagc-3' (SEQIDN0:69),
[0111] 5' -gggaagcgugaaccauuuu-3' (SEQIDN0:70),
[0112] 51 -agcugccuuuaugucugcu-3/(SEQIDNO:71),
[0113] 5' -cacagugcugauggauuug-3' (SEQIDN0:72),
[0114] 5' -agucagaguugaacaggua-3' (SEQIDN0:73),
[0115] 5' -uggaagcaguaacaugcaa-3' (SEQIDN0:74),
[0116] 5' -agaagaguaugauaacgaa-3' (SEQIDNO:75),
[0117] 5' -gaagcgugaaccauuuucu-3' (SEQIDN0:76),
[0118] 5' -ggcuauauugucgaugauu-3' (SEQIDN0:77),
[0119] 5' -gacaagagaauggaaaugu-3' (SEQIDNO:78),
[0120] 5' -ugaaaugccuucuaguagu-3' (SEQIDN0:79),
[0121] 5' -gugagugaaaugccuucua-3' (SEQIDN0:80),
[0122] 5' -gaccucaaugacaccuacu-3' (SEQ ID NO:81),
[0123] 5' -ccucaaugacaccuacucu-3' (SEQ ID NO:82),
[0124] 5' -gcugauggauuugagguua-3' (SEQ ID NO:83),
[0125]5' -ggaagcaguaacaugcaaa-3' (SEQ ID NO:84),
[0126] 5' -caguaacaugcaaauguca-3' (SEQ ID N0:85),
[0127]5' -ggaccucaaugacaccuac-3' (SEQ ID NO:86),
[0128] 5' -cagccauagcugccuuuau-3' (SEQ ID N0:87),
[0129] 5' -uccaugaaaacucacagca-3' (SEQ ID N0:88),
[0130] 5' -gcugccuuuaugucugcug-3' (SEQ ID N0:89),
[0131] 5' -gcucuugauacucggcuca-3' (SEQ ID N0:90),
[0132] 5' -ugcugcuggauuggaccuc-3' (SEQ ID N0:91),
[0133] 5' -gaaccacaaauaccuggcu-3' (SEQ ID N0:92),
[0134] 5' -agagcaccuggaagcagua-3' (SEQ ID N0:93),
[0135] 5' -caccuggaagcaguaacau-3' (SEQ ID N0:94),
[0136]5' -cugaggaacgaaagaaacu-3' (SEQ ID NO:95),
[0137] 5' -gugaaaugccuucuaguag-3' (SEQ ID N0:96),
[0138] 5' -cuacucugggaagcgugaa-3' (SEQ ID NO:97),
[0139] 5' -cugggaagcgugaaccauu-3' (SEQ ID NO:98),
[0140] 5' -acuacucagaagaguauga-3' (SEQ ID N0:99),
[0141] 5' -caugcaaaugucagcaaga-3' (SEQ ID NO:100),
[0142] 5' -ugagguuaccucaagaagu-3' (SEQ ID NO:101),
[0143] 5' -acucggcucaggccauuau-3' (SEQ ID NO:102),
[0144] 5' -uucacggagaaugcaaaua-3
当前第2页1 2 3 4 5 6 
网友询问留言 已有0条留言
  • 还没有人留言评论。精彩留言会获得点赞!
1